We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VNOM:NASDAQViper Energy, Inc. Analysis

Data as of 2026-05-09 - not real-time

$46.79

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Viper Energy (VNOM) trades at $46.79, just above its 20‑day SMA of $47.62 and comfortably above the 50‑day SMA of $46.59, indicating a short‑term bullish bias despite a bearish MACD histogram. The stock shows a neutral RSI of 46.5 and a high 30‑day volatility of 31.8%, while its beta of 0.27 suggests limited systematic risk. Fundamentally, the company boasts a 4.92% dividend yield with a 97% payout ratio, but earnings are negative (trailing EPS –$0.57) and free cash flow is –$1.04 B, raising sustainability concerns. Debt is steep at a debt‑to‑equity of 15.5, and the ROE is –1.8%.
The latest material news lifts the outlook: management raised full‑year oil production guidance by ~2.5% and announced a $337 M acquisition of royalty acres, supporting organic growth of >5% YoY. Analyst sentiment is upbeat, with a Zacks Rank 2 Buy upgrade and inclusion among top U.S. energy picks. A discounted cash‑flow model values the shares at $79.5, implying roughly 22% upside, while the forward PE of 19 is modestly below the industry average of 20.3. These factors combine to create a compelling valuation case, but the high debt load, negative cash conversion, and near‑full dividend payout inject notable risk.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near support with bullish SMA alignment
  • Production guidance raise and acquisition boost earnings outlook
  • High dividend yield attracting income‑focused investors

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued DCF fair value indicating ~22% upside
  • Forward PE modestly below industry average
  • Continued dividend income supporting total return

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Elevated debt‑to‑equity ratio and negative free cash flow
  • Dividend payout near 100% of earnings, questioning sustainability
  • Sector exposure to commodity price cycles and regulatory environment

Key Metrics & Analysis

Financial Health

Revenue Growth120.30%
Profit Margin-2.89%
P/E Ratio19.0
ROE-1.84%
ROA5.17%
Debt/Equity15.47
P/B Ratio1.8
Op. Cash Flow$1.2B
Free Cash Flow$-1044625024
Industry P/E20.3

Technical Analysis

TrendBullish
RSI46.5
Support$44.05
Resistance$51.13
MA 20$47.62
MA 50$46.59
MA 200$40.74
MACDBearish
VolumeStable
Fear & Greed Index90.73

Valuation

Fair Value$79.51
Target Price$57.06
Upside/Downside21.94%
GradeUndervalued
TypeBlend
Dividend Yield4.92%

Risk Assessment

Beta0.27
Volatility31.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.